Rhodococcus erythropolis MTHt3 biotransforms ergopeptines to lysergic acid by Thamhesl, Michaela et al.
Thamhesl et al. BMC Microbiology  (2015) 15:73 
DOI 10.1186/s12866-015-0407-7RESEARCH ARTICLE Open AccessRhodococcus erythropolis MTHt3 biotransforms
ergopeptines to lysergic acid
Michaela Thamhesl1, Elisabeth Apfelthaler2, Heidi Elisabeth Schwartz-Zimmermann2, Elisavet Kunz-Vekiru2,
Rudolf Krska2, Wolfgang Kneifel3, Gerd Schatzmayr1 and Wulf-Dieter Moll1*Abstract
Background: Ergopeptines are a predominant class of ergot alkaloids produced by tall fescue grass endophyte
Neotyphodium coenophialum or cereal pathogen Claviceps purpurea. The vasoconstrictive activity of ergopeptines
makes them toxic for mammals, and they can be a problem in animal husbandry.
Results: We isolated an ergopeptine degrading bacterial strain, MTHt3, and classified it, based on its 16S rDNA
sequence, as a strain of Rhodococcus erythropolis (Nocardiaceae, Actinobacteria). For strain isolation, mixed microbial
cultures were obtained from artificially ergot alkaloid-enriched soil, and provided with the ergopeptine ergotamine
in mineral medium for enrichment. Individual colonies derived from such mixed cultures were screened for ergota-
mine degradation by high performance liquid chromatography and fluorescence detection. R. erythropolis MTHt3
converted ergotamine to ergine (lysergic acid amide) and further to lysergic acid, which accumulated as an end
product. No other tested R. erythropolis strain degraded ergotamine. R. erythropolis MTHt3 degraded all ergopeptines
found in an ergot extract, namely ergotamine, ergovaline, ergocristine, ergocryptine, ergocornine, and ergosine, but
the simpler lysergic acid derivatives agroclavine, chanoclavine, and ergometrine were not degraded. Temperature
and pH dependence of ergotamine and ergine bioconversion activity was different for the two reactions.
Conclusions: Degradation of ergopeptines to ergine is a previously unknown microbial reaction. The reaction end
product, lysergic acid, has no or much lower vasoconstrictive activity than ergopeptines. If the genes encoding
enzymes for ergopeptine catabolism can be cloned and expressed in recombinant hosts, application of
ergopeptine and ergine degrading enzymes for reduction of toxicity of ergot alkaloid-contaminated animal feed
may be feasible.Background
Ergot alkaloids occur widely in nature because some
ergot alkaloid-producing fungi form intricate associations
with plants. Such associations range from mutualistic
endosymbiotic life of Neotyphodium or Epichloë species as
endophytes in certain grasses [1], and Periglandula species
in morning glory [2], to parasitic association of Claviceps
species with rye, sorghum and other cereal plants [3].
Ergot alkaloids in plants naturally discourage mammals
from feeding, which is one of the proposed advantages for
plants to harbour endophytic fungi. The underlying
toxicity of ergot alkaloids can be a problem in animal
husbandry, and a detoxification technology to increase* Correspondence: dieter.moll@biomin.net
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unless otherwise stated.nutritive value and safety of animal feed would be
beneficial.
Ergopeptines typically represent a major proportion of
total ergot alkaloids both in sclerotia, which are hard,
pigmented mycelium structures formed by Claviceps
purpurea as wintering bodies on cereal ears, and in
endophyte infected grass. In ergopeptines, cyclic tripep-
tides are linked to D-lysergic acid by an amide bond
(Figure 1). There is tryptophan at position two of the
tripeptide in ergotamine (one of the predominant ergo-
peptines in sclerotia of C. purpurea), whereas there is
valine at this position in ergovaline (the predominant
ergopeptine in endophyte-infected grass) [4]. Lysergic
acid derivatives, including ergopeptines, can undergo
epimerisation at the chiral carbon atom C-8. The left-
hand rotation isomers (C-8(R) configuration) are pharma-
cologically active, and are named with the suffix –ine (e.g.,ral . This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Structures of ergopeptines, lysergic acid and ergine.
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configuration) have lower or no pharmacological activity,
and are named with the suffix –inine (e.g., ergotaminine)
[5]. Pharmacological activity is based on structural similar-
ity to neurotransmitters serotonin, dopamine, epinephrine
or norepinephrine [6], and ergot alkaloids have found a
number of medical uses including treatment of migraine
[7], Parkinson’s disease [8], prolactin-related disorders [9],
or in obstetrics [10,11]. One important effect of ergot al-
kaloids in mammals is vasoconstriction: Typical symp-
toms of ergot alkaloid poisoning of humans in previous
centuries included skin discoloration and gangrene of
hands or feet, caused by constriction of blood vessels, and
called St. Anthony’s Fire. Fescue toxicosis, a kind of
poisoning that animals may display after consumption of
ergot alkaloids by grazing on pastures of tall fescue (Fes-
tuca arundinacea) infected with Neotyphodium coeno-
phialum, typically includes symptoms that are related to
restricted blood flow in the peripheral vascular system.
Such symptoms are changes in body temperature and res-
piration rate, fat necrosis, dry gangrene or necrosis of tail
tips, ear tips or hooves, and may even include loss of
hooves [12-14]. Ergopeptines were found to elicit strong
vasoconstriction, whereas lysergic acid caused much less
or no contractile response [15-19]. An agronomically im-
portant symptom of ergot alkaloid poisoning, reduced
feed intake and reduced weight gain, has also been related
to vasoconstriction [17,19,20].Ergot alkaloid poisoning of humans is mostly consid-
ered a problem of the past, because sclerotia of C. pur-
purea in rye or other grains can be removed by grain
cleaning in mills. In animal nutrition, ergot alkaloid poi-
soning mostly concerns ruminants grazing on endophyte
infected pastures of tall fescue. The economic loss
caused by ergot alkaloids in animal husbandry in the
United States was estimated in 1993 to be $ 600 million
per year [21], and is likely to have increased to over $ 1
billion per year [13,22]. It has been attempted to in-
crease the tolerance of animals to ergot alkaloids on tall
fescue pastures by providing adsorbents as feed additives
[23-26]. As an alternative, biological detoxification
through microbial or enzymatic degradation has been in-
vestigated for other mycotoxins [27-29]. Ergot alkaloids
were also found to be susceptible to microbial degrad-
ation, during rumen fermentation [30] or in earthworm
intestine [31]. Bioconversion of ergine to lysergic acid by
a Rhodococcus equi strain, in the meantime re-classified
as R. erythropolis [32], has been reported [33], but mi-
crobial strains that can transform or metabolise ergopep-
tines have never been described.
The aim of our work was to explore microbial and en-
zymatic detoxification of ergot alkaloids with the long
term goal of developing a feed additive to ameliorate
toxicity of ergot alkaloid-contaminated feed. In our
screening for ergot alkaloid-degrading microbial strains,
we used ergotamine and ergine as substrates, because
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substances may be responsible for ergot alkaloid-toxicosis
because of their vasoconstrictive activity. We isolated a
new bacterial strain, Rhodococcus erythropolis MTHt3,
which converted ergopeptines to ergine and further to ly-
sergic acid. Characterisation of the strain’s ergopeptine
conversion activity suggested that the reactions are likely
catalysed by two separate enzymes, which may, if they are
identified and produced in recombinant hosts, be suitable
for an application to reduce toxicity of ergot alkaloid-
contaminated animal feed.
Results
Isolation and taxonomic assignment of strain MTHt3
We attempted to isolate ergot alkaloid-degrading micro-
bial strains from samples of soil, rumen fluid, and mites
and weevils which infested our stock of sclerotia. Deg-
radation of the ergot alkaloids used as screening sub-
strate, ergotamine and ergine, was repeatedly observed
when sample resuspensions in various growth media or
buffers were incubated with substrate under aerobic or
anaerobic conditions. Biological activity could be distin-
guished from substrate adsorption by using autoclaved
samples as negative controls and by recording time
curves. However, none of the strains isolated from such
habitats, directly or after enrichment, showed ergota-
mine degradation activity, and only one of the strains
degraded ergine. We also screened 98 bacterial strains
and 96 yeast strains from a local, proprietary strain col-
lection for ergotamine or ergine bioconversion activity.
Five bacterial and five yeast strains with ergine bioconver-
sion activity, but no strains with ergotamine bioconversion
activity, were found. The product of ergine bioconversion
was always lysergic acid.
A sample of soil, in which ground sclerotia had been
buried three months earlier, was resuspended in M2 buf-
fer, which provides no source of nitrogen, and used for
degradation experiments. This soil suspension showed
degradation of repeatedly added doses of ergotamine.
The first two of four doses of ergotamine, which were
added in three days intervals, were only partially de-
graded. After addition of the third or fourth dose of er-
gotamine, in parallel samples, ergotamine concentration
was reduced to zero within the three days interval. How-
ever, cell densities in these mixed culture biotransform-
ation reactions remained low, and no change in optical
absorption was observed. The cultures were plated on
M2 agar with ergotamine. Colonies and microbial film
grown on such plates were washed off and resuspended
in M2 buffer with ergotamine, and ergotamine conver-
sion was measured. Reduction of ergotamine concentra-
tion in these resuspensions suggested that active strains
were able to grow on M2-ergotamine-agar. Two of 158
individually tested colonies showed ergotamine and alsoergine degradation. The isolates in the two colonies had
identical 16S rDNA sequence and were considered sister
colonies of the same strain, coded MTHt3. The 16S
rDNA sequence was identical with annotated 16S rDNA
sequence (1520 bp) in the whole genome sequence of
Rhodococcus erythropolis PR4 (GenBank NC_012490),
an alkane degrading strain [34], and of R. erythropolis
CCM 2595 (GenBank NC_022115), a phenol degrading
strain [35]. There was a mismatch of one base compared
with 16S rDNA of R. erythropolis type strain DSM
43066T (GenBank X79289): Position 25, according to
numbering of PR4 16S rDNA as annotated, is G in DSM
43066T, but C in MTHt3, PR4 and CCM 2595. Strain
DSM 44595, originally deposited as type strain of Nocar-
dia coeliaca but re-classified as R. erythropolis, had its
16S rDNA sequenced as part of an effort to make miss-
ing sequences of named species available [36], and it is
also identical to MTHt3. Compared with the 1520 bp
16S rDNA sequence of MTHt3, type strains of other
species had, in the available length of their 16S sequences,
9 mismatches (R. qingshengii djl-6T, GenBank DQ090961,
and R. jialingiae djl-6-2T, GenBank DQ185597), 12 mis-
matches (R. baikonurensis GTC 1041 T, GenBank
AB071951), 23 mismatches (R. globerulus DSM 4954,
GenBank X80619), or more mismatches. None of the
other R. erythropolis strains (Table 1) we tested with high
biomass concentration and long incubation time con-
verted ergotamine. One strain (DSM 11397) transformed
ergine to lysergic acid, but the reaction was slower than
with strain MTHt3 (Figure 2).
Characterisation of ergot alkaloid-biodegradation by MTHt3
To record a time course of ergotamine and ergine bio-
conversion, R. erythropolis MTHt3-biomass was resus-
pended at lower concentration, 2% of the maximum
OD600 reached in tryptone soya broth (TSB). Ergotamine
was degraded quickly, ergine appeared as an intermedi-
ate produced by ergotamine degradation, and ergine was
converted, more slowly, to lysergic acid (Figure 3). The
data shown in Figure 3 are from single biotransform-
ation reactions, but previous biotransformation reactions
with different biomass concentrations and sampling
times showed similar results. The final lysergic acid con-
centration was about equimolar to the ergotamine or
ergine starting concentration. In order to find out which
ergot alkaloids other than the ones used as screening
substrates for strain isolation are degraded by R. erythro-
polis MTHt3, an ergot alkaloid extract from Claviceps
purpurea sclerotia was prepared, and MTHt3 was incu-
bated with this extract (Figure 4). Absolute quantifica-
tion of ergot alkaloid concentrations was difficult
because of an apparent increase of concentration over
the course of incubation due to buffer evaporation in
sample and negative control. Also, concentrations of
Table 1 List of Rhodococcus strains
Strain Properties Reference
R. erythropolis MTHt3 (DSM 25948) degrades ergot alkaloids present work
R. erythropolis DSM 11397 nitrile hydratase (NHase) producer Layh et al. [49]
R. erythropolis DSM 20665 degrades picolilic acid Koch et al. [77]
R. erythropolis DSM 43066T type strain Goodfellow and Alderson [78]
R. erythropolis DSM 43188 fixes nitrogen Metcalfe and Brown [79]
R. erythropolis PR4 degrades alkanes Komukai-Nakamura et al. [80]
Rhodococcus sp. DSM 16550 (previously classified as R. erythropolis) degrades 1-haloalkanes Kulakova et al. [81]
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inine forms [5] had to be summed up as peak areas
because the quantities of analytical standards we had
available for each substance were not enough for method
calibration and accurate quantification. Of the ergot
alkaloids that were detectable with a multi-mycotoxin
analysis method [37], R. erythropolis MTHt3 catalysed
bioconversion of all ergopeptines, but not of the lysergic
acid derivatives ergometrine (also called ergonovine or
ergobasine), agroclavine and chanoclavine. As in the ex-
periment with pure ergotamine (Figure 3), ergopeptine
degradation was faster than ergine degradation. No
major differences between the transformation rates of
the various ergopeptines were apparent. Presumably due
to the low concentration of biomass used for reaction
with the ergot-extract, ergine concentration increased
rather than decreased over the observed incubation
period, similar to the concentration of lysergic acid. Corre-
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contained biomass of R. erythropolis strains at OD600nm = 2.0, which was eq
of the maximum OD600nm reached in TSB, in sodium phosphate buffer pH
with shaking. Strains are referenced in Table 1.with pH and with temperature are shown in Figures 5
and 6. Ergotamine degradation activity was high in the
range of pH 7.0 to 10.0 and 25°C to 42°C. Ergine deg-
radation activity was high at pH 7.0, and below 35°C.
Both reactions proceeded only slowly at pH 5.0 or
below.
Discussion
Availability of an ergot alkaloid-degrading bacterial strain
might be the starting point for an application in animal
nutrition to ameliorate fescue toxicosis of grazing rumi-
nants or ergot alkaloid poisoning of other animals. Fescue
toxicosis is a considerable concern in animal husbandry
and since several ways of suppressing toxicosis [14], in-
cluding binding agents for use as feed additives [24], have
been investigated, such an application would likely be met
with demand from some farmers. Considering a feed
additive application for Rhodococcus erythropolis MTHt3,
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Figure 3 Concentration of ergot alkaloids after incubation of ergotamine (A) or ergine (B) with R. erythropolis MTHt3, or buffer alone.
Biomass concentration: 2% of maximum cell density reached in TSB; buffer: Teorell-Stenhagen buffer pH 7.0; ergot alkaloid starting concentration:
5 mg/l (=8.6 μM ergotamine or 18.7 μM ergine). Plotted data are from single biotransformation reactions.
Thamhesl et al. BMC Microbiology  (2015) 15:73 Page 5 of 13strain be considered a biological hazard or safe? Is ergot
alkaloid-degradation a metabolic activity that is shown by
many microbial strains, or is the activity unique for R. ery-
thropolis MTHt3? Which of the different ergot alkaloids
produced by Claviceps purpurea, Neotyphodium coeno-
phialum, or other fungi, are degraded by the strain and
which are persistent? What are the end products of deg-
radation, and will degradation also reduce toxicity? Could
an application of the strain as live microbial feed additive
be considered, and would activity in animal gastrointes-
tinal tract be high enough to allow degradation of ergot
alkaloids before they are absorbed? Would it make sense
to attempt cloning of the genes responsible for degrad-
ation, and consider production of enzymes for use as feed
additive in recombinant hosts?We repeatedly observed reduction of added ergota-
mine concentration in some but not all mixed cultures
derived from environmental samples. Although we could
not isolate more ergopeptine degrading strains from
such cultures, microbial ergopeptine degradation activity
is likely not unique to R. erythropolis MTHt3, but may
be more widespread in the environment. R. erythropolis
MTHt3 or other ergotamine-biotransforming strains may
have been able to propagate in our enrichment cultures,
because subsequent but not initial doses of ergotamine
were consumed in the three day incubation period, but if
any growth has occurred it was too low for changes in op-
tical density of the culture to record. Possible effects of
acetonitrile, which was used as solvent for ergotamine,
were not investigated. A database search with the 16S
Figure 4 Concentration of ergot alkaloids in Claviceps purpurea ergot-extract incubated with R. erythropolis MTHt3. Extract was incubated
with R. erythropolis MTHt3 (■) at 1.6% of maximum cell density reached in TSB, or in the same sodium phosphate buffer without biomass (○) (data
from single flasks plotted; peak areas determined by LC/ESI-MS/MS; not calibrated).
Thamhesl et al. BMC Microbiology  (2015) 15:73 Page 6 of 13rDNA sequence of strain MTHt3 showed that the strain
can be classified with certainty as belonging to the genus
Rhodococcus, and probably to the species R. erythropolis.
Rhodococci are aerobic, gram-positive, non-motile nocar-
dioform actinomycetes [38]. Members of the genus Rho-
dococcus are widespread in the environment and most
common within the microbiota of soil [39]. There are vari-
ous applications of members of the genus Rhodococcus in
industrial and environmental biotechnology, mostly for
bioremediation and biodegradation [39-43], but also for
bioflocculant and acrylamide production [43]. Some iso-
lates of Rhodococcus species were also described as cap-
able of degrading mycotoxins aflatoxin B1 [44,45], T2toxin [46] and zearalenone [47,48], and hydrolysis of
ergine to lysergic acid has been reported for R. equi A4
[33] (re-classified R. erythropolis [32]). In the present
work, two more Rhodococcus isolates catalysed this ergine
to lysergic acid hydrolysis reaction: Our new isolate R. ery-
thropolis MTHt3, and one of our reference strains, R. ery-
thropolis DSM 11397, which has been described as nitrile
hydratase (NHase) producer [49]. However, degradation
or biotransformation of ergopeptines by an isolated micro-
bial strain has, to our knowledge, never been reported be-
fore. Our comparison with reference strains showed, that
ergopeptine degradation was specific for isolate MTHt3,
and not a general physiological activity of R. erythropolis.
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plants or humans. A full safety evaluation considered R.
erythropolis strain C2 safe for use in bioremediation of oil
spills [50]. The pathogenic Rhodococcus species, R. equi, a
pathogen of horses, and R. fascians, a plant pathogen, are
not closely related to MTHt3 and require virulence plas-
mids for pathogenicity [51,52]. R. erythropolis MTHt3 can
be considered safe for work in the laboratory and as a pos-
sible donor of genes for heterologous expression and re-
combinant enzyme production, but for use as live microbial
feed additive, careful safety evaluation would nevertheless
have to be performed.15 20 25 30 35 40 45
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indicates that R. erythropolis MTHt3 cannot cleave the
ergoline ring system. The benefit of ergopeptine catabol-
ism for R. erythropolis MTHt3 may be to utilise frag-
ments of the cyclic tripeptide moiety of ergopeptines,
and the amine group of ergine, for cellular metabolism.
We have started to work on isolation and identification
of reaction products formed from the tripeptide moiety
of ergopeptines. For the bacterium, the tripeptide moiety
may be an easier target for further catabolism than the
ergoline ring. It seems unlikely that after separation from
the ergoline ring, fragments of the cyclic tripeptide may
still have vasoconstrictive activity since no structural
similarity to neurotransmitters is given, but other ergot
alkaloid related or unrelated pharmacological activity
cannot be ruled out.
Ergopeptines are known as the predominant and most
physiologically active ergot alkaloids produced by the
grass endophyte N. coenophialum or the cereal pathogen
C. purpurea [4]. The biodegradation activity of R. ery-
thropolis MTHt3 may therefore be able to reduce tox-
icity of ergot alkaloids in contaminated feed for animals.
Our findings that lysergic acid accumulated as an end
product of ergopeptine degradation, and that the ergot
alkaloids agroclavine, chanoclavine, and ergometrine
were not degraded, at least not in the complex mixture
we used, pose limitations to possible animal feed detoxi-
fication applications of R. erythropolis MTHt3. Likely,
other ergot alkaloids which are not ergopeptines will
also not be degraded, and such alkaloids can also have
effects on animals. Agroclavine shows antibiotic activity,
interacts weakly with neurotransmitter receptors [53],
and has low vasoconstrictive potential [54]. For chano-
clavine, in vitro studies suggest a weak affinity for D-2
receptors [55], whereas in vivo chanoclavine has no ef-
fect [56]. Ergometrine is one of the main ergot alkaloids
produced by C. purpurea [57]. In drunken horse grass
(Achnatherum inebrians) infected by the endophytic
fungus N. gansuense, high levels of ergometrine were
also detected [58], but in endophyte-infected tall fescue,
only minor concentrations of ergometrine were found[59]. Ergometrine stimulates uterine contractility and re-
duces plasma prolactin concentration for a short period
after treatment [60,61]. Compared with ergopeptines,
ergometrine induces a similar contractile response in a
bovine lateral saphenous vein bioassay [62] and a rumi-
nal artery assay [17], but it doesn’t have vasoconstrictive
effect in a ruminal vein bioassay [17] or cytotoxic effects
in cell culture [63].
In tall fescue infected with N. coenophialum, ergova-
line is known as the predominant ergot alkaloid [64,65],
but ergine can occur in similar concentrations [66], and
both ergot alkaloids are converted to lysergic acid by R.
erythropolis MTHt3. Lysergic acid is also a product of
ergot alkaloid-metabolism by ruminal microorganisms
[67]. Compared to ergopeptines, lysergic acid has
lower toxic potential and vascular constriction was
only observed with high concentrations of lysergic acid
[15,16], or not at all [17,19]. In vitro studies indicate
that ergovaline, but not lysergic acid, bioaccumulates
with repetitive exposure [68], and ergopeptines are
persistent in vasoconstriction, whereas lysergic acid
and ergoline alkaloids including ergometrine are not
[69]. The conclusion of these studies is that conversion
of ergopeptines and ergine to lysergic acid should re-
duce toxicity.
Biodegradation with R. erythropolis MTHt3 may cause
a transient increase of ergine concentration. Ergine was
found to have vasoconstrictive activity similar to ergo-
peptines in vitro [70], but conversion of ergopeptines to
ergine could have in vivo effects that are not obvious to
predict. In summary, ergot alkaloid poisoning in animal
nutrition is always caused by several alkaloids in a mix-
ture, and composition of this mixture can vary. Biodeg-
radation of ergopeptines with R. erythropolis MTHt3, or
its enzymes, will likely reduce toxicity, but the degree of
toxicity reduction may depend on the original compos-
ition of ergot alkaloids in a mixture.
Conversion of ergotamine to lysergic acid was fast with
high biomass concentration (Figure 2), but took several
hours with lower biomass concentration (Figure 3), and
would probably take at least equally long in vivo, for
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loids from tall fescue in rumen fluid was reported to
proceed slowly over many hours [67], and the pH (Figure 5)
and temperature (Figure 6) conditions that allowed
MTHt3 to biotransform ergotamine and ergine cov-
ered the range that is considered typical for bovine
rumen [71,72], it doesn’t seem likely that ergopeptine
degradation activity of aerobic bacterium R. erythropolis
MTHt3 would be sufficient for detoxification in an anaer-
obic environment such as bovine rumen. However, an
animal feed additive application based on recombinant
enzymes for ergopeptine and ergine degradation might
be feasible. Recombinant enzymes could potentially
offer several advantages, including possibilities to use
higher activity doses for faster biotransformation, to
adapt to reaction conditions by enzyme engineering, to
prevent accumulation of an intermediate product by
tuning doses of separate enzymes to each other, and to
avoid stability and safety issues associated with live
strains. We are proceeding with work on identification of
ergopeptine degradation genes of R. erythropolis MTHt3.
Conclusions
Our isolation of R. erythropolis MTHt3 and characterisa-
tion of its ergot alkaloid-degradation may serve as a new
starting point for future development of a technology to
reduce toxicity of ergot alkaloid-contaminated animal
feed, because degradation of ergopeptines by a microbial
isolate has not been reported before. The strain may not
be sufficiently active for use as a live microbial feed
additive, but its enzymes might be suitable for detoxifi-
cation, or for production of precursor molecules for
pharmaceutical applications. It seems worthwhile to at-
tempt cloning of the genes responsible for ergopeptine
and ergine biotransformation.
Methods
Ergot alkaloids and other chemicals
Ergotamine D-tartrate was from Sigma-Aldrich (St.
Louis, MO, USA). Ergine, erginine, ergotaminine, and ly-
sergic acid were from Alfarma s.r.o. (Cernošice, Czech
Republic). Glacial acetic acid (HAc), aqueous ammonia
solution, and Methanol (MeOH; LC gradient grade)
were from Merck (Darmstadt, Germany). HPLC-grade
acetonitrile was from VWR international (West Chester,
PA, USA). Ergot alkaloids were dissolved in acetonitrile
for use as analytical standards or as stock solutions for
degradation experiments, with the exception of ergine
which was dissolved in acetonitrile/water (30/70, v/v) for
preparation of stock solutions for degradation experi-
ments. Concentrations of stock solutions for degradation
experiments were 250 mg/l for ergotamine and 650 mg/l
for ergine. All other chemicals were from Sigma-Aldrich
(St. Louis, MO, USA).Isolation and cultivation of ergot alkaloid-degrading
strain MTHt3
Sclerotia were obtained from an Austrian mill, where
they were collected from naturally contaminated rye by
an optical separation system. Sclerotia were ground
(Series II® Mill, RomerLabs, Tulln, Austria), and about
200 g per spot were buried about 8 to 12 cm deep at
three different spots in a field near Königsdorf, Southern
Burgenland, Austria, in June. Soil samples from the spots
were taken 3 months later, and 2 g portions of soil were
suspended in 18 ml M2 medium spiked with 5 mg/l er-
gotamine as a nitrogen source. M2 medium is a modi-
fied, nitrogen-free version of Brunner mineral medium
(DSMZ medium 457, German Collection of Microorgan-
isms and Cell Cultures; http://www.dsmz.de/microor-
ganisms/medium/pdf/DSMZ_Medium457.pdf ) contain-
ing 2.44 g Na2HPO4, 1.52 g KH2PO4, 0.20 g MgSO4 × 7
H2O, 0.05 g CaCl2 × 2 H2O, 1 g glucose, and 10.0 ml
trace element solution 4 (without EDTA) in 1000 ml dis-
tilled water. The soil resuspensions were shaken at 25°C
and 200 rpm for 14 d, and in 3 d intervals, samples for
high performance liquid chromatography and fluores-
cence detection (HPLC-FLD) analysis were taken, and
fresh ergotamine was added to additional nominal con-
centration of 5 mg/l. The enrichment cultures were used
to make tenfold serial dilutions. Aliquots of dilution
stage 10^-2 to 10^-5 were spread on plates of M2 (con-
taining 1.5% agar and 5 mg/l ergotamine) and incubated
at 25°C until colonies appeared. Individual colonies were
streaked on fresh M2-ergotamine-plates to obtain pure
cultures. Single colonies from these plates were inocu-
lated into 5 ml M2 medium with 5 mg/l ergotamine or
ergine. These cultures were incubated at 25°C and
200 rpm in the dark for 7 d, and concentrations of er-
gotamine and ergine were determined by HPLC-FLD.
Ergotamine degrading isolate MTHt3 was subsequently
cultivated in TSB (Oxoid Limited, Hampshire, UK) at
25°C and 200 rpm, and cryo-conserved in this medium
with 10% glycerol at −80°C. Strain MTHt3 was deposited
at DSMZ with the assigned number DSM 25948.
Strain identification
Taxonomic assignment of strain MTHt3 was initially made
by PCR amplification of 16S rDNA using universal primers
27F (5′- AGA GTT TGA TCM TGG CTC AG −3′) and
1492R (5′- TAC GGY TAC CTT GTT ACG ACT T −3′)
[73], and sequencing. For PCR amplification, MTHt3 was
grown overnight in TSB as described, and 1 μl culture was
added directly to PCR reaction buffer (10 μl 5x Phusion™
HF buffer, 200 μM of each dNTP, 0.5 μM of each primer
and 1 U of Phusion™ high-fidelity DNA polymerase
(Finnzymes Oy, Vantaa, Finland); final volume: 50 μl).
PCR was performed in a thermocycler (Mastercycler
gradient, Eppendorf, Hamburg, Germany) according to
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cles of 10 s at 98°C, 20 s at 53.7°C, 45 s at 72°C; and a
final extension step at 72°C for 10 min. PCR product
was purified by QIAquick PCR purification kit (Qiagen)
according to the manufacturer’s instructions. Sanger
sequencing (primers 27F and 1492R) was performed by
VBC-BIOTECH Service GmbH (Vienna, Austria). More
recently, the whole genome of Rhodococcus erythropolis
MTHt3 was sequenced to support ergopeptine biotrans-
formation gene identification and cloning. Genomic
DNA of strain MTHt3 was prepared from the biomass
pellet of an overnight culture (100 ml TSB, 25°C,
200 rpm) by using Qiagen Genomic-tip 500/G kit
(Hilden, Germany). Cell lysis was enhanced by addition
of mutanolysin (200 U/ml) and by prolonging incuba-
tion to 4 h at 37°C. Whole-genome sequencing was per-
formed by LGC Genomics GmbH (Berlin, Germany)
using Roche 454 technology. The previously obtained
16S rDNA sequence was confirmed and extended to
1520 bp, matching the annotation of R. erythropolis PR4
(GenBank NC_012490) and R. erythropolis CCM 2595
(GenBank NC_022115) whole genome sequences. Taxo-
nomic assignment was made by submitting 16S rDNA
sequence to the ribosomal database project (https://
rdp.cme.msu.edu/index.jsp [74]) for alignment with full-
length 16S sequences of type strains, to EzTaxon (http://
www.ezbiocloud.net/eztaxon [75]), and to BLAST (http://
blast.ncbi.nlm.nih.gov/Blast.cgi).
Biodegradation of ergotamine and ergine with other
Rhodococcus erythropolis strains
Bacterial strains (Table 1), presently classified or at the
time of use classified as R. erythropolis, were obtained
from DSMZ (http://www.dsmz.de/). Strains were grown
overnight in TSB (25°C, 200 rpm), biomass was collected
by centrifugation (2 655 × g, 20°C, 5 min) and resus-
pended in the same volume of 50 mM sodium phos-
phate buffer pH 7.0. These resuspensions and the same
buffer were mixed to make 10 ml aliquots with optical
density (OD600nm) 2.0, and spiked with 5 mg/l ergota-
mine or ergine. Controls were the same spiked buffer
without inoculation, and incubated under the same
conditions (25°C, 200 rpm). Samples were taken period-
ically, processed as described below, and stored at −20°C
until analysis by HPLC-FLD.
Incubation of R. erythropolis MTHt3 with ergot extract
A suspension of MTHt3 was made by inoculating the
strain in TSB and cultivating for 20 h, collecting biomass
from 5 ml culture by centrifugation (2 655 × g; 10 min),
and resuspending it in 5 ml 50 mM sodium phosphate
buffer pH 7.0. Ergot extract was prepared by shaking
20 g ergot meal, obtained as described above, with 80 ml
acetonitrile/water (1/1, v/v) for 2 h at room temperature.This crude extract was filtered (“White Ribbon Filter”,
Grade 589/2: 4–12 μm; Whatman plc, Kent, UK),
concentrated almost to dryness by rotary evaporation
(Heidolph VV2011, Schwabach, Germany) and lyophi-
lised (Christ, Osterode am Harz, Germany). Lyophilisate
was dissolved (125 mg in 4 ml acetonitrile/water (1:1, v/v))
and filter-sterilised (Filtropur S, 0.2 μm, Sarstedt,
Nümbrecht, Germany). One ml of this ergot extract
was added to 0.08 ml MTHt3 suspension and 3.92 ml
50 mM sodium phosphate buffer pH 7.0, and the
spiked suspension was incubated at 25°C and 200 rpm.
Samples were taken and analysed by liquid chromatog-
raphy/electrospray ionisation tandem mass spectrometry
(LC/ESI-MS/MS) as previously described [37]. Negative
control samples were taken from parallel incubation of
the same, sterile ergot extract in the same buffer volume
without MTHt3.
Time course of ergotamine and ergine bioconversion
Strain MTHt3 was grown for 17 h in TSB at 25°C and
200 rpm. Biomass was harvested by centrifugation
(2 655 × g, 20°C, 5 min) and resuspended in the same
volume Teorell-Stenhagen universal buffer pH 7.0 (cit-
rate, phosphate and borate; [76]). The MTHt3 suspen-
sion was diluted 1/50 with Teorell-Stenhagen universal
buffer pH 7.0, spiked with 5 mg/l ergotamine or ergine,
and incubated at 25°C and 200 rpm. Samples were taken
periodically, processed, and analysed by HPLC-FLD as
described below.
pH and temperature dependence of ergotamine and
ergine bioconversion
An overnight culture of MTHt3 was prepared as de-
scribed above. Biomass was harvested by centrifugation
(2 655 × g, 20°C, 5 min) and resuspended in the same
volume Teorell-Stenhagen universal buffer pH 7.0 for
the pH dependence experiment, or in 50 mM sodium
phosphate buffer pH 7.0, for the temperature depend-
ence experiment. Teorell-Stenhagen universal buffer pre-
pared at pH values from 3.0 to 11.0 was spiked with
ergotamine or ergine (final concentration: 5 mg/l), inoc-
ulated with 1/50 volume MTHt3 suspension, and incu-
bated at 25°C without shaking. At the end of the
incubation period, pH was measured and verified. Refer-
ence reactions were identical but without biomass. Shak-
ing was omitted because previous results showed that
shaking had no effect on ergot alkaloid-biotransformation
by MTHt3, but affected buffer pH, presumably due to
higher carbon dioxide exposure. For determination of cor-
relation of activity with temperature, 50 mM sodium
phosphate buffer, pH 7.0, spiked with 5 mg/l ergotamine
or ergine, was set to temperatures from 15°C to 45°C by
incubation in water baths, inoculated with 1/50 volume
MTHt3 suspension, and further incubated without
Thamhesl et al. BMC Microbiology  (2015) 15:73 Page 11 of 13shaking. Negative controls, identical but without biomass,
were incubated at the same temperatures. Samples from
the pH and temperature experiments were taken at sev-
eral time points and processed for HPLC-FLD analysis as
described below. Time points 2 h for ergotamine biotrans-
formation and 10 h for ergine biotransformation were
chosen for the graphs in Figures 5 and 6, because bio-
transformations were just complete or nearly complete
under the reaction conditions giving the highest activities.Sample analysis by high performance liquid
chromatography and fluorescence detection (HPLC-FLD)
Concentrations of ergotamine and ergine, their epimeric-
inine forms and lysergic acid were determined by HPLC-
FLD on an HP 1100 system (Agilent, Waldbronn,
Germany) equipped with a G1321A fluorescence de-
tector. Samples from degradation experiments were
centrifuged (10 621 × g, 20°C, 10 min), and 320 μl ali-
quots of supernatant were transferred to amber glass
vials. Eighty μl acetonitrile was added, and the mix-
tures were vortexed and stored at −20°C until analysis.
Mobile phases A (methanol:water 10/90, v/v) and B
(methanol:water 80/20, v/v) contained 25 mM glacial
acetic acid and were set to pH 8.0 with ammonia solu-
tion. The column thermostat of the HPLC system was
kept at 20°C, the flow rate was set to 0.5 ml/min, and
the injection volume to 10 μl. Elution was performed
in gradient elution mode (0 min: 30% B, 2 min: 100% B,
4 min: 100% B, 4.2 min: 30% B, 7 min: 30% B for lyser-
gic acid, ergine, and erginine; or 0 min: 30% B, 2 min:
100% B, 5.5 min: 100% B, 5.6 min: 30% B, 8.5 min: 30% B
for lysergic acid, ergine, ergotamine and their epimers) on
a Gemini C18 column (50 × 2 mm, 5 μm particle size;
Phenomenex, Aschaffenburg, Germany). The fluorescence
detector was set to excitation at 310 nm and emission at
415 nm. Concentrations of ergot alkaloids and their re-
spective epimers were added up.
Nucleotide sequence accession number The 16S
rDNA gene sequence of R. erythropolis MTHt3 was de-
posited at NCBI GenBank under accession number
KM047507.
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